December 16, 2020 10:54 AM EST
News Briefing

News brief­ing: Bob Cough­lin is jump­ing in­to re­al es­tate — in a big way; Keytru­da plus Lenvi­ma posts pos­i­tive PhI­II da­ta in en­dome­tri­al can­cer

John Carroll

Editor & Founder

We know now where Mass­Bio chief Bob Cough­lin is head­ed. JLL re­ports that Cough­lin is join­ing the bro­kers hatch­ing new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

FDA re­moves hold on three CARs­gen CAR-T tri­als; Ono pass­es on itolizum­ab

Ex­clu­sive: Women’s health uni­corn Maven Clin­ic cuts 10% of its work­force weeks af­ter rais­ing $125M

Bax­ter pulls IV prod­ucts out of Chi­na to shift sup­ply to the US

A service from the Financial Times